All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32701823

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32701823	D67N	RT	gag-pol	HIV Infections	D G L	View
2	32701823	E138A	RT	gag-pol	HIV Infections	D G L	View
3	32701823	E138G	RT	gag-pol	HIV Infections	D G L	View
4	32701823	E138K	RT	gag-pol	HIV Infections	D G L	View
5	32701823	E138Q	RT	gag-pol	HIV Infections	D G L	View
6	32701823	E138R	RT	gag-pol	HIV Infections	D G L	View
7	32701823	F227C	RT	gag-pol	HIV Infections	D G L	View
8	32701823	G140S	IN	gag-pol	HIV Infections	D G L	View
9	32701823	H221Y	RT	gag-pol	HIV Infections	D G L	View
10	32701823	K101E	RT	gag-pol	HIV Infections	D G L	View
11	32701823	K101P	RT	gag-pol	HIV Infections	D G L	View
12	32701823	K103N	RT	gag-pol	HIV Infections	D G L	View
13	32701823	K103S	RT	gag-pol	HIV Infections	D G L	View
14	32701823	K219E	RT	gag-pol	HIV Infections	D G L	View
15	32701823	K219N	RT	gag-pol	HIV Infections	D G L	View
16	32701823	K219Q	RT	gag-pol	HIV Infections	D G L	View
17	32701823	K219R	RT	gag-pol	HIV Infections	D G L	View
18	32701823	K65E	RT	gag-pol	HIV Infections	D G L	View
19	32701823	K65N	RT	gag-pol	HIV Infections	D G L	View
20	32701823	K65R	RT	gag-pol	HIV Infections	D G L	View
21	32701823	K70E	RT	gag-pol	HIV Infections	D G L	View
22	32701823	K70R	RT	gag-pol	HIV Infections	D G L	View
23	32701823	L100I	RT	gag-pol	HIV Infections	D G L	View
24	32701823	L210W	RT	gag-pol	HIV Infections	D G L	View
25	32701823	L74I	RT	gag-pol	HIV Infections	D G L	View
26	32701823	L74V	RT	gag-pol	HIV Infections	D G L	View
27	32701823	L90M	PR	gag-pol	HIV Infections	D G L	View
28	32701823	M184I	RT	gag-pol	HIV Infections	D G L	View
29	32701823	M184V	RT	gag-pol	HIV Infections	D G L	View
30	32701823	M230I	RT	gag-pol	HIV Infections	D G L	View
31	32701823	M230L	RT	gag-pol	HIV Infections	D G L	View
32	32701823	M41L	RT	gag-pol	HIV Infections	D G L	View
33	32701823	M46I	PR	gag-pol	HIV Infections	D G L	View
34	32701823	M46L	PR	gag-pol	HIV Infections	D G L	View
35	32701823	N155H	IN	gag-pol	HIV Infections	D G L	View
36	32701823	N155S	IN	gag-pol	HIV Infections	D G L	View
37	32701823	Q148H	IN	gag-pol	HIV Infections	D G L	View
38	32701823	Q151M	RT	gag-pol	HIV Infections	D G L	View
39	32701823	Q58E	PR	gag-pol	HIV Infections	D G L	View
40	32701823	R263K	IN	gag-pol	HIV Infections	D G L	View
41	32701823	S147G	IN	gag-pol	HIV Infections	D G L	View
42	32701823	T215F	RT	gag-pol	HIV Infections	D G L	View
43	32701823	T215Y	RT	gag-pol	HIV Infections	D G L	View
44	32701823	T69D	RT	gag-pol	HIV Infections	D G L	View
45	32701823	T97A	IN	gag-pol	HIV Infections	D G L	View
46	32701823	V179L	RT	gag-pol	HIV Infections	D G L	View
47	32701823	Y115F	RT	gag-pol	HIV Infections	D G L	View
48	32701823	Y143H	IN	gag-pol	HIV Infections	D G L	View
49	32701823	Y181C	RT	gag-pol	HIV Infections	D G L	View
50	32701823	Y181I	RT	gag-pol	HIV Infections	D G L	View
51	32701823	Y181V	RT	gag-pol	HIV Infections	D G L	View
52	32701823	Y188L	RT	gag-pol	HIV Infections	D G L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.